- July 12, 2017 @ 9:00 - 6:00
- Cost: 299-999
- T 650 268 9744 | M 702 508 5202 ext 8063 (USA)
Gastro 2017 will focus on Exploring new dimensions of Gastroenterology, which covers a wide range of critically important sessions from basic research to innovations in the area of Gastroenterology diseases and other Metabolic syndromes.
Conference Keynotes and Organizing Committee Includes
1. Dr. Francesco Marotta, Italy
2. Dr. David H. Van Theil, USA
3. Larry Good, USA
4. Antonio Iannetti, Italy
Gastro 2017 aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of gastrointestinal diseases. It helps in promoting the advancement of gastroenterology. It mainly focuses on the latest diagnostic and therapeutic techniques for gastric diseases. It discusses the latest research outcomes and technological advancements in the field and brings together leading gastroenterologists, surgeons, physicians, research scholars, students along with industrial and pharma professionals to exchange share their views on critical aspects of gastroenterology research.
Gastrointestinal cancer is the leading cause of cancer death in Europe. Europe is considered as second largest market of gastrointestinal disorder therapeutics. This European Gastroenterology conference also provides the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of Gastrointestinal therapeutics.
Gastrointestinal disorders are also the most common cancer in men and the second most common in women after breast cancer. “Bariatric surgery” is a general need for further research into the incidence, prognosis and public health burden of many gastrointestinal disorders across Europe.
Recent studies of market value of GI therapeutics for major diseases in the eight major markets is expected to decrease in value from $6.8 billion in 2012 to $6.6 billion by 2019 forecasts business intelligence provider GBI Research. The major factors currently stabilizing the market include the increasing prevalence of GI diseases, growing awareness of the importance of detecting these diseases early and the availability of effective diagnostics creates an urgent need for organizing this gastroenterologist’s conference.
Asia-Pacific region is the emerging market for gastrointestinal disorders market because of rising incidences of peptic ulcer, ulcerative colitis, irritable bowel syndrome and chron’s disease.
The session of our conference includes, but not limited to
Pediatric Gastroenterology and Nutrition,
Gastroenterology Nursing / Endoscopy nursing,
Inflammatory bowel disease,
Viral Hepatitis and Liver Fibrosis
Hepatocellular Carcinoma (Liver Cancer),